CRISPR Insider™

CRISPR News and Information from Around The World

New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue

Posted by btwatson on February 7, 2018 8:26 am
Tags:
Categories: Uncategorized

Source: New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue

[unable to retrieve full-text content]

  1. New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue  Science Daily
  2. New CRISPR method efficiently corrects DMD defect in heart tissue  Phys.Org
  3. Two Types of CRISPR Gene Editing Could Be Useful in Treating Sickle Cell Anemia, Editas Reports  Sickle Cell Anemia News
  4. Full coverage

Published at Tue, 06 Feb 2018 19:57:56 +0000

Leave a Reply Cancel reply

You must be logged in to post a comment.

< CRISPR Insider™ home

Crispr News

  • Safety buttons for CRISPR/Cas9 - Drug Discovery News
    September 26, 2023
  • Is Crispr Therapeutics AG (CRSP) Stock at the Top of the Biotechnology Industry? - InvestorsObserver
    September 26, 2023
  • CRISPR & Cas Genes Market worth $27.21 billion by 2030 | Cumulative Impact of COVID-19, Russia Ukraine Conflic - openPR
    September 26, 2023
  • Plant Breeding and CRISPR Plants Market 2023-2030 Share, Growth Statistics, Business Strategies, Major Pl - Benzinga
    September 26, 2023
  • The Future is CRISPR - Modern Farmer
    September 26, 2023
  • Genetic Engineering in Agriculture Market Expected to Grow at 6.5 ... - Digital Journal
    September 26, 2023
  • An unexpected component in retinal survival - ASBMB Today
    September 26, 2023
  • CRISPR Market Research Report by Size and Share 2023 | Latest Development, Growth Statistics and Forecast - Benzinga
    September 26, 2023
  • Viewpoint: European concessions to green activists undermine their ... - Genetic Literacy Project
    September 26, 2023
  • CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio - Yahoo Finance
    September 25, 2023
  • Specific genes allow immune T-cells to infiltrate the brain in MS... - Multiple Sclerosis News Today
    September 25, 2023
  • A compendium of viruses from methanogenic archaea reveals their ... - Nature.com
    September 25, 2023
  • Systematic profiling of conditional pathway activation identifies ... - Nature.com
    September 25, 2023
  • Harpe Bioherbicide Solutions, Inc. Signs License Agreement for ... - PR Newswire
    September 25, 2023
  • New President True to Aldevron's Core - Genetic Engineering & Biotechnology News
    September 25, 2023
  • CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
    CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
  • CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
  • The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
    The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
  • The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
  • ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
    ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
  • The Dark Side of CRISPR – Scientific American
    The Dark Side of CRISPR – Scientific American
  • ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
    ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
  • Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
    Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
  • DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
    DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
  • CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
    CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
  • Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
    Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
  • New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
    New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
  • After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
    After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
  • Load more [+]

Copyright 2020 CrisprInsider.com